Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer
Open Access
- 15 October 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (20), 6043-6048
- https://doi.org/10.1158/1078-0432.ccr-06-1064
Abstract
Purpose: Hepatoma-derived growth factor (HDGF) is a nucleus-targeted growth factor playing an important role in the development and progression of cancers. This study investigated the correlation of HDGF expression and prognosis in patients with pancreatic ductal carcinoma.Keywords
This publication has 27 references indexed in Scilit:
- Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular CarcinomaAnnals of Surgical Oncology, 2006
- Down-regulation of Hepatoma-Derived Growth Factor Inhibits Anchorage-Independent Growth and Invasion of Non–Small Cell Lung Cancer CellsCancer Research, 2006
- Expression of Hepatoma-Derived Growth Factor Is Correlated with Lymph Node Metastasis and Prognosis of Gastric CarcinomaClinical Cancer Research, 2006
- Hepatoma-derived Growth FactorJournal of Biological Chemistry, 2005
- Hepatoma-derived Growth Factor Is a Neurotrophic Factor Harbored in the NucleusPublished by Elsevier BV ,2004
- Expression of hepatoma‐derived growth factor in hepatocellular carcinomaCancer, 2003
- Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferationHepatology, 2002
- Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular developmentJCI Insight, 2000
- An endothelial growth factor involved in rat renal development.JCI Insight, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958